Skip to main content

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Investor Securities Class Action Lawsuit 12/09/2024

  • If you purchased shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX), you have certain options and for certain investors are short and strict deadlines running. Deadline: February 7, 2025. NASDAQ: KYTX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

December 09, 2024 - An investor in shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Kyverna Therapeutics, Inc. in connection with certain allegedly false and misleading statements that were made in connection with Kyverna Therapeutics’ initial pub...



You must register (for free) or login to view the entire case.